Growth hormone deficiency in pseudohypoparathyroidism type 1a: Another manifestation of multihormone resistance

Emily L. Germain-Lee, Joshua Groman, Janet L. Crane, Suzanne M. Jan De Beur, Michael A. Levine

Research output: Contribution to journalArticle

Abstract

Albright hereditary osteodystrophy (AHO) is a genetic disorder caused by heterozygous inactivating mutations in GNAS1, the gene encoding the α-chain of Gs, and is associated with short stature, obesity, brachydactyly, and sc ossifications. AHO patients with GNAS1 mutations on maternally inherited alleles also manifest resistance to multiple hormones (e.g. PTH, TSH, LH, FSH), a variant termed pseudohypoparathyroidism (PHP) type 1a, due to paternal imprinting of Gαs transcripts in specific tissues. Recent evidence has shown that Gαs transcripts are also imprinted in the pituitary somatotrophs that secrete GH. Because this imprinting could influence GHRH-dependent stimulation of somatotrophs, we hypothe-sized that maternally inherited GNAS1 mutations would impair GH secretion. We studied GH status in 13 subjects with PHP type 1a. GH responses to arginine/L-dopa and arginine/GHRH were deficient in nine subjects, all of whom were obese and had low serum concentrations of IGF-I. By contrast, none of the four GH-sufficient subjects were obese, and all had normal IGF-I levels. Our data indicate that GH deficiency is common (69%) in PHP type 1a and may contribute to the obesity and short stature typical of AHO. We propose that GH status be evaluated in all patients with PHP type 1a.

Original languageEnglish (US)
Pages (from-to)4059-4069
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume88
Issue number9
DOIs
StatePublished - Sep 1 2003

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this